Important Updates to Clinician Administered Drug Policies – Please Review

Date: 12/30/25

Arkansas Total Care is amending or implementing new policies. Please see the table below for a list of these policies and their effective dates. 

Policy	Policy Name	Revision	Effective Date
CP.PMN.154	Isavuconazonium (Cresemba)	Per SDC, added redirection to posaconazole for mucormycosis and aspergillosis if member is age ≥ 13 years and had prior inadequate response (i.e., refractory or progressive aspergillosis) to voriconazole	3/1/2026